← SynDRA
NAXAGOLIDE
SynDRA canonical compound SYN0003028 — structure-anchored drug synonym record
| Clinical phase | Phase 3 |
| Primary target(s) | DRD2 |
| Mechanism of action | dopamine receptor agonist |
All known targets
Mechanisms of action (all sources)
- dopamine receptor agonist
- DRD2 MODULATOR
Drug classes
Cross-references
Synonyms
- Naxagolida
- (r,r)-phno
- Dopazinol
- Nazagolide
- PHNO
- Naxagolide hydrochloride
- L-647339
- MK-458
- (+)-PHNO
- dopazinol
- Naxagolidum
- (+)-4-Propyl-9-hydroxynaphthoxazine
- CHEBI:177372
- (11C)(+)-PHNO
- 4-propyl-9-hydroxynaphthoxazine
- 4-Propyl-9-hydroxy-1,2,3,4a,5,6-hexahydronaphthoxazine
- N-0500
- (11C)-(+)-PHNO
- (11C)-(+)-propyl-hexahydro-naphtho-oxazin
- RefChem:164887
- DTXCID90159273
- Naxagolide [INN]
- Naxagolidum [INN-Latin]
- Naxagolida [INN-Spanish]
- UNII-22Z7E0X6OF
- JCSREICEMHWFAY-HUUCEWRRSA-N
- (+)-PHNO; (R,R)-PHNO; Dopazinol; Nazagolide
- SCHEMBL221758
- orb1705793
- PHNO,(+)
- GLXC-04938
- BDBM50020217
- BDBM50331552
- EX-A10985
- AKOS005146337
- MS-23506
- HY-108237
- CS-0027625
- NS00122463
Look up NAXAGOLIDE in the interactive SynDRA portal →